Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AbbVie Goes Boldly Into Immuno-Neurology With Alector

24 Oct 2017

• By Jessica Merrill

Human brain illustrated with millions of small nerves - Conceptual 3d render

Related Content

Neuroscience Reaches A New Inflection Point, Big Biotechs Say

25 Jan 2017

Merck’s Biotech Pipeline Gets A Boost From Two Acquisitions

09 May 2006

Related Companies

AbbVie Inc.

Alector, Inc.

Bristol Myers Squibb Company

Biogen, Inc.

Pfizer Inc.

Amgen, Inc.

Merck & Co., Inc.

AbbVie Inc.

Additional Topics

Deals Innovation Research & Development Neurology BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.